Probiotics and muscle health: the impact of Lactobacillus on sarcopenia through the gut-muscle axis
Frontiers in Microbiology · 14.03.2025 · 16
DOI: 10.3389/fmicb.2025.1559119 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 14.03.2025. Verfasst von Jingjun Zhu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Sarcopenia refers to the decline in skeletal muscle mass and function. Due to its increased mortality rate and severe disability, the clinical importance of sarcopenia is becoming increasingly prominent. Although the exact cause of sarcopenia is not fully understood, the gut microbiota (GM) plays a crucial role in the pathogenesis of sarcopenia, and increasing evidence suggests that gut dysbiosis may be associated with disease development. In the past few decades, the use of probiotics has surged, few studies have explored their impact on sarcopenia prevention and treatment. Lactobacillus probiotics are commonly used for gut health and immune support, but their mechanism in sarcopenia via the gut-muscle axis remains uncertain. This review highlights the treatment challenges, GM’s role in sarcopenia, and the potential of Lactobacillus as an adjunct therapy. In addition, we also discuss the possible mechanisms by which Lactobacillus affect muscle function, such as alleviating inflammatory states, clearing excessive reactive oxygen species (ROS), improving skeletal muscle metabolism, enhancing intestinal barrier function and modulating the gut microbiota and its metabolites. These mechanisms may collectively contribute to the preservation of muscle mass and function, offering a promising avenue for advancing microbial therapies for sarcopenia.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
- Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, China.
- Department of Hepatobiliary Pancreatic Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
- Department of Radiology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.
Zitieren
APA
Zhu, J., Peng, F., Yang, H., Luo, J., Zhang, L., Chen, X., Liao, H., Lei, H., Liu, S., Yang, T., Luo, G., Chen, G., & Zhao, H. (2025). Probiotics and muscle health: the impact of Lactobacillus on sarcopenia through the gut-muscle axis. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1559119
Vancouver
Zhu J, Peng F, Yang H, Luo J, Zhang L, Chen X, et al. Probiotics and muscle health: the impact of Lactobacillus on sarcopenia through the gut-muscle axis. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1559119
BibTeX
@article{Zhu2025,
author = {Zhu, Jingjun and Peng, Fei and Yang, Huixin and Luo, Jing and Zhang, Li and Chen, Xiaolong and Liao, Huazhi and Lei, Hao and Liu, Shuai and Yang, Tingqian and Luo, Guanghua and Chen, Guodong and Zhao, Heng},
title = {Probiotics and muscle health: the impact of Lactobacillus on sarcopenia through the gut-muscle axis},
journal = {Frontiers in Microbiology},
year = {2025},
volume = {16},
doi = {10.3389/fmicb.2025.1559119}
}
EUVIMED